2010
Survival of Hepatitis C Virus in Syringes: Implication for Transmission among Injection Drug Users
Paintsil E, He H, Peters C, Lindenbach BD, Heimer R. Survival of Hepatitis C Virus in Syringes: Implication for Transmission among Injection Drug Users. The Journal Of Infectious Diseases 2010, 202: 984-990. PMID: 20726768, PMCID: PMC2932767, DOI: 10.1086/656212.Peer-Reviewed Original ResearchConceptsHepatitis C virusInjection drug usersDrug usersC virusHigh prevalenceInsulin syringesViable virusTuberculin syringesHCV infectivityResidual volumeReporter virusDay 1Prevention strategiesDay 7Microculture assayDay 63VirusLuciferase activitySyringesDegrees CPrevalenceVirus survivalSurvivalVirus decay ratesDays
2009
Hepatitis C virus infection among drug injectors in St Petersburg, Russia: social and molecular epidemiology of an endemic infection
Paintsil E, Verevochkin SV, Dukhovlinova E, Niccolai L, Barbour R, White E, Toussova OV, Alexander L, Kozlov AP, Heimer R. Hepatitis C virus infection among drug injectors in St Petersburg, Russia: social and molecular epidemiology of an endemic infection. Addiction 2009, 104: 1881-1890. PMID: 19712125, PMCID: PMC2763027, DOI: 10.1111/j.1360-0443.2009.02687.x.Peer-Reviewed Original ResearchConceptsInjection drug usersHepatitis C virusRespondent-driven samplingPrevalent infectionMajority of IDUsHepatitis C virus infectionSustained virological responseC virus infectionRespondent-driven sampleAssociation of genotypesIDU communityVirological responseHCV infectionAntiviral therapyC virusGenotype 3aDrug injectionVirus infectionDrug injectorsBlood samplesHCV sequencesDrug usersEndemic infectionInfectionMolecular epidemiology
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply